EyePoint Pharmaceuticals

Aug 06, 2025

•

Jun 30, 2025

EyePoint Pharmaceuticals Q2 2025 Earnings Report

Estimated Revenue:$6.82M

-30.3% YoY

Estimated EPS:-$0.82

50.3% YoY

EyePoint Pharmaceuticals

Unlock previous datapoints

Upgrade

EyePoint Pharmaceuticals

Unlock previous datapoints

Upgrade

Loading...

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View EyePoint Pharmaceuticals

Key Statistics

Market Cap

$1.12B

P/E Ratio

-5.50

Sector

N/A

Industry

N/A

52-Week High

$18.8

52-Week Low

$4.11

Products

Get in Touch

Resources

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals Q2 2025 Earnings Report

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals

Historical Earnings Impact

Avg. Return Before/After Earnings

Company Overview

Key Statistics